We found for
Documento de debate sobre la fijación de precios en función de la indicación (IBP) ¿Deben variar los precios de los medicamentos según la indicación?
![IBP Cover](https://www.ohe.org/wp-content/uploads/2019/06/IBP-Cover.jpg)
The WHO Technical Report on the Pricing of Cancer Medicines: Missing a central role for HTA and value assessment
![WHO-cancer-medicines-rebrand](https://www.ohe.org/wp-content/uploads/2019/05/WHO-cancer-medicines-rebrand.png)
Value, Access, and Incentives for Innovation: Policy Perspectives on Alternative Models for Pharmaceutical Rebates
![Value, Access, and Incentives for Innovation - Policy Perspectives on Alternative Models for Pharmaceutical Rebates](https://www.ohe.org/wp-content/uploads/2019/03/Value-Access-and-Incentives-for-Innovation-Policy-Perspectives-on-Alternative-Models-for-Pharmaceutical-Rebates.jpg)